TP53 and colorectal carcinoma: Our results shed new insights into the highly potent anticancer activity of OSW-1 (Supplementary Fig. 14), which primarily induces p53/PUMA-mediated and RIP1/RIP3-independent necroptosis to kill CRC cells.